These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 9442787)

  • 61. [Short-term efficacy of intravitreal injection of melphalan for refractory vitreous seeding from retinoblastoma].
    Xue K; Ren H; Zhang R; Yuan YF; Qian J
    Zhonghua Yan Ke Za Zhi; 2017 Aug; 53(8):570-574. PubMed ID: 28851196
    [No Abstract]   [Full Text] [Related]  

  • 62. Treatment of intraocular retinoblastoma with vincristine and carboplatin.
    Rodriguez-Galindo C; Wilson MW; Haik BG; Merchant TE; Billups CA; Shah N; Cain A; Langston J; Lipson M; Kun LE; Pratt CB
    J Clin Oncol; 2003 May; 21(10):2019-25. PubMed ID: 12743157
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Effectiveness of intravitreal chemotherapy-assisted endoresection in monocular patients with group D retinoblastoma.
    Yu X; Li X; Xing Y; Lu S; Tanumiharjo S; Ma J
    BMC Cancer; 2020 Aug; 20(1):808. PubMed ID: 32847550
    [TBL] [Abstract][Full Text] [Related]  

  • 64. In vivo growth of retinoblastoma in a newborn infant.
    Shah PK; Narendran V; Kalpana N
    Indian J Ophthalmol; 2010; 58(5):421-3. PubMed ID: 20689200
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Chemoreduction in the initial management of intraocular retinoblastoma.
    Shields CL; De Potter P; Himelstein BP; Shields JA; Meadows AT; Maris JM
    Arch Ophthalmol; 1996 Nov; 114(11):1330-8. PubMed ID: 8906023
    [TBL] [Abstract][Full Text] [Related]  

  • 66. The outcome of chemoreduction treatment in patients with Reese-Ellsworth group V retinoblastoma.
    Gündüz K; Shields CL; Shields JA; Meadows AT; Gross N; Cater J; Needle M
    Arch Ophthalmol; 1998 Dec; 116(12):1613-7. PubMed ID: 9869790
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Regression patterns in treated retinoblastoma with chemotherapy plus focal adjuvant therapy.
    Ghassemi F; Rahmanikhah E; Roohipoor R; Karkhaneh R; Faegh A
    Pediatr Blood Cancer; 2013 Apr; 60(4):599-604. PubMed ID: 23034769
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Practical approach to management of retinoblastoma.
    Shields CL; Mashayekhi A; Demirci H; Meadows AT; Shields JA
    Arch Ophthalmol; 2004 May; 122(5):729-35. PubMed ID: 15136321
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Preliminary results of primary chemotherapy in retinoblastoma.
    Bornfeld N; Schüler A; Bechrakis N; Henze G; Havers W
    Klin Padiatr; 1997; 209(4):216-21. PubMed ID: 9293453
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Diffuse infiltrating retinoblastoma with central nervous system metastasis.
    Khetan V; Al-Kharusi N; Ganesh A; Al-Futaisi A; Biswas J; Kumar K; Raja T
    Arch Ophthalmol; 2011 Mar; 129(3):375-7. PubMed ID: 21403001
    [No Abstract]   [Full Text] [Related]  

  • 71. HAND-HELD OPTICAL COHERENCE TOMOGRAPHY MONITORING OF CHEMORESISTANT RETINOBLASTOMA.
    Malik K; Welch RJ; Shields CL
    Retin Cases Brief Rep; 2020; 14(4):368-371. PubMed ID: 29443806
    [TBL] [Abstract][Full Text] [Related]  

  • 72. [Results of combined chemotherapy and local ophtalmic therapy for intraocular retinoblastoma].
    Balwierz W; Pietrys D; Romanowska-Dixon B; Kobylarz J; Pawińska-Wasikowska K; Moryl-Bujakowska A
    Przegl Lek; 2010; 67(6):404-8. PubMed ID: 21344770
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Spectral Domain Optical Coherence Tomography Reveals Hidden Fovea Beneath Extensive Vitreous Seeding From Retinoblastoma.
    Hasanreisoglu M; Dolz-Marco R; Ferenczy SR; Shields JA; Shields CL
    Retina; 2015 Jul; 35(7):1486-7. PubMed ID: 25756924
    [No Abstract]   [Full Text] [Related]  

  • 74. Trilateral retinoblastoma: potentially curable with intensive chemotherapy.
    Dunkel IJ; Jubran RF; Gururangan S; Chantada GL; Finlay JL; Goldman S; Khakoo Y; O'Brien JM; Orjuela M; Rodriguez-Galindo C; Souweidane MM; Abramson DH
    Pediatr Blood Cancer; 2010 Mar; 54(3):384-7. PubMed ID: 19908299
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Chemoreduction for retinoblastoma: analysis of tumor control and risks for recurrence in 457 tumors.
    Shields CL; Mashayekhi A; Cater J; Shelil A; Meadows AT; Shields JA
    Trans Am Ophthalmol Soc; 2004; 102():35-44; discussion 44-5. PubMed ID: 15747743
    [TBL] [Abstract][Full Text] [Related]  

  • 76. [Results of combined chemoreduction and local treatment for intraocular retinoblastoma].
    Kobylarz J; Piwowarczyk A; Romanowska-Dixon B; Balwierz W; Dłuzniewska A
    Klin Oczna; 2006; 108(1-3):55-9. PubMed ID: 16883942
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Intra-arterial chemotherapy for retinoblastoma: report No. 1, control of retinal tumors, subretinal seeds, and vitreous seeds.
    Shields CL; Bianciotto CG; Jabbour P; Ramasubramanian A; Lally SE; Griffin GC; Rosenwasser R; Shields JA
    Arch Ophthalmol; 2011 Nov; 129(11):1399-406. PubMed ID: 21670328
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Multimodal Therapy for Stage III Retinoblastoma (International Retinoblastoma Staging System): A Prospective Comparative Study.
    Chawla B; Hasan F; Seth R; Pathy S; Pattebahadur R; Sharma S; Upadhyaya A; Azad R
    Ophthalmology; 2016 Sep; 123(9):1933-9. PubMed ID: 27449712
    [TBL] [Abstract][Full Text] [Related]  

  • 79. The Potential Benefit of Three vs. Six Cycles of Carboplatin, Etoposide, and Vincristine in Postenucleation High-Risk Patients with IRSS Stage I Retinoblastoma.
    Ye H; Du Y; Chen R; Luo X; Mao Y; Ai S; Ma W; Ding Y; Li Q; Yang H
    Curr Eye Res; 2016 Nov; 41(11):1507-1512. PubMed ID: 27158739
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Tumor Regression Patterns in Retinoblastoma.
    Zafar SN; Siddiqui SN; Zaheer N
    J Coll Physicians Surg Pak; 2016 Nov; 26(11):896-899. PubMed ID: 27981923
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.